• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Basilea Pharmaceutica Ltd. (SIX: BSLN)

Basilea Pharmaceutica Ltd. is an integrated biopharmaceutical company headquartered in Basel, Switzerland, listed on the SWX Swiss Exchange (SWX:BSLN). Basilea is currently focused on the research, development and commercialization of new antibacterial, antifungal and dermatology drugs in the hospital and specialty care setting. *

 

	Start	2000-10-01 splitoff
	Group	Basilea (Group)
	Predecessor	Roche (Group)
	Industry	antibiotic
	Industry 2	dermatic
	Person	Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board)
	Person 2	Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries)
	Region	Basel BS
	Country	Switzerland
	Street	487 Grenzacherstr.
	City	4058 Basel BS
	Tel	+41-61-606-1111
		Address record changed: 2020-12-02
Basic data	Employees	D: 101 to 500 (2017-12-31)
	Currency	CHF
	Annual sales	101,521,000 (revenue, total, consolidated (2017) 2017-12-31)
	Profit	-19,360,000 (2017-12-31)
	Cash	200,724,000 (2017-12-31)
		* Document for �About Section�:
		Record changed: 2020-05-09

Advertisement

More documents for Basilea (Group)

• [1] Coulter Partners. (7/4/18). "Press Release: Coulter Partners Secures Chief Technology Officer for Basilea Pharmaceutica International Ltd."....
• [2] Basilea Pharmaceutica Ltd.. (3/1/18). "Press Release: Basilea Names Adesh Kaul as New Member of its Management Committee". Basel....
• [3] Basilea Pharmaceutica Ltd.. (2/27/18). "Press Release: Basilea Reports Significantly Improved Financial Results in 2017". Basel....
• [4] Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel....
• [5] Basilea Pharmaceutica Ltd.. (2/21/18). "Press Release: Basilea's CEO Ronald Scott Will Retire. Chief Commercial Officer David Veitch Named as Successor – Changes in the Board of Directors". Basel....
• [6] Basilea Pharmaceutica Ltd.. (1/10/18). "Press Release: Basilea Announces Completion of the License Agreement Extension with Pfizer for Antifungal Cresemba for China and Asia Pacific". Basel....
• [7] Basilea Pharmaceutica Ltd.. (12/1/17). "Press Release: Basilea Extends Existing License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) to China and Asia Pacific". Basel....
• [8] Basilea Pharmaceutica Ltd.. (9/28/17). "Press Release: Basilea Announces License Agreement for Antibiotic Zevtera (ceftobiprole) with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd.". Basel....
• [9] Basilea Pharmaceutica Ltd.. (8/10/17). "Press Release: Basilea Reports Improved Financial Results in Half-year 2017 Driven by Growing Product Sales, Significant Progress on Partnering and Development Programs". Basel....
• [10] Basilea Pharmaceutica Ltd.. (7/20/17). "Press Release: Basilea Announces Completion of the License Agreement with Pfizer for Antifungal Cresemba for Europe, Russia, Turkey and Israel". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.